{"id":2409,"date":"2020-02-28T10:10:24","date_gmt":"2020-02-28T09:10:24","guid":{"rendered":"https:\/\/www.aica3.org\/cms\/?p=2409"},"modified":"2022-01-04T17:26:49","modified_gmt":"2022-01-04T16:26:49","slug":"il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b","status":"publish","type":"post","link":"https:\/\/www.aica3.org\/cms\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\/","title":{"rendered":"Il decorso clinico della calpainopatia (LGMD2A) e della disferlinopatia (LGMD2B)"},"content":{"rendered":"
\n
\n
\n

The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B)<\/strong><\/p>\n

\n
\n
\n
\n
\n
\n
\n
\n

Neurological Research 2010 VOL 32 NO 1<\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n

Author: <\/strong>C. Angelini, L. Nardetto, C. Borsato, R. Padoan, M. Fanin, A. C. Nascimbeni and E. Tasca<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
\n
\n
\n
\n

Objective:<\/strong> Autosomal recessive limb girdle muscular dystrophies (LGMD type 2) are a clinically and genetically heterogeneous group of disorders, characterized by progressive involvement and wasting of limb girdle muscles. In order to describe the peculiar clinical features of LGMD2A (calpainopathy) and LGMD2B (dysferlinopathy), the most frequent forms of LGMD in European countries, we analysed and compared the phenotype and the clinical course in two relatively large groups of these patients. Methods: We selected 22 patients with a molecular diagnosis of LGMD2A and 21 patients with LGMD2B and reported their clinical data collected from both clinical history and during periodical neuromuscular examinations: age and distribution of muscle involvement at onset, clinical functional score by the use of ten-point modified scale of Gardner\u2013Medwin and Walton at onset and at last clinical examination, and the rate of disease progression.<\/p>\n

Results:<\/strong> LGMD2A group included patients with different ages at onset (early-onset or late-onset), different phenotypes (upper girdle in Erb LGMD or lower girdle in Leyden\u2013Moebius LGMD) and different disease progressions (rapid or slow course). LGMD2B patients differed for pattern of muscle involvement at onset (distal in Miyoshi dystrophy or proximal in Leyden\u2013Moebius LGMD) but they had a rather homogeneous age at onset (in the second\/third decade) and rate of disease progression.<\/p>\n

Discussion:<\/strong> Our data show that besides the clinical differences within each group of patients, the two forms of LGMD present distinctive clinical features. The various phenotypes and courses can be attributed to specific pathogenetic mechanisms and might suggest differential therapeutic strategies.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\"\"<\/td>\n\n

Scarica Articolo completo<\/a><\/h3>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B) Neurological Research 2010 VOL 32 NO 1 Author: C. Angelini, L. Nardetto, C. Borsato, R. Padoan, M. Fanin, A. C. Nascimbeni and E. Tasca Objective: Autosomal recessive limb girdle muscular dystrophies (LGMD type 2) are a clinically and genetically heterogeneous group of disorders, characterized by progressive […]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[34,33],"tags":[43,41,42,44],"class_list":["post-2409","post","type-post","status-publish","format-standard","hentry","category-articoli-scientifici","category-ricerca-e-pubblicazioni","tag-calpain-3","tag-clinical-course","tag-dysferlin","tag-lgmd"],"yoast_head":"\nIl decorso clinico della calpainopatia (LGMD2A) e della disferlinopatia (LGMD2B) - AICa3 - ETS - Associazione Italiana Calpaina 3<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.aica3.org\/cms\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Il decorso clinico della calpainopatia (LGMD2A) e della disferlinopatia (LGMD2B) - AICa3 - ETS - Associazione Italiana Calpaina 3\" \/>\n<meta property=\"og:description\" content=\"The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B) Neurological Research 2010 VOL 32 NO 1 Author: C. Angelini, L. Nardetto, C. Borsato, R. Padoan, M. Fanin, A. C. Nascimbeni and E. Tasca Objective: Autosomal recessive limb girdle muscular dystrophies (LGMD type 2) are a clinically and genetically heterogeneous group of disorders, characterized by progressive […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.aica3.org\/cms\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\/\" \/>\n<meta property=\"og:site_name\" content=\"AICa3 - ETS - Associazione Italiana Calpaina 3\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/pages\/AICa3-Associazione-Italiana-Calpaina-3\/119599211561350\" \/>\n<meta property=\"article:published_time\" content=\"2020-02-28T09:10:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-04T16:26:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.aica3.org\/cms\/wp-content\/uploads\/2016\/12\/Graphicloads-Filetype-Pdf-150x150.png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/#\\\/schema\\\/person\\\/8a5e19b3ab1d1aa2190043f3ddb89aa2\"},\"headline\":\"Il decorso clinico della calpainopatia (LGMD2A) e della disferlinopatia (LGMD2B)\",\"datePublished\":\"2020-02-28T09:10:24+00:00\",\"dateModified\":\"2022-01-04T16:26:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\\\/\"},\"wordCount\":302,\"image\":{\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/wp-content\\\/uploads\\\/2016\\\/12\\\/Graphicloads-Filetype-Pdf-150x150.png\",\"keywords\":[\"Calpain-3\",\"clinical course\",\"dysferlin\",\"LGMD\"],\"articleSection\":[\"Articoli scientifici\",\"Ricerca e Pubblicazioni\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\\\/\",\"url\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\\\/\",\"name\":\"Il decorso clinico della calpainopatia (LGMD2A) e della disferlinopatia (LGMD2B) - AICa3 - ETS - Associazione Italiana Calpaina 3\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/wp-content\\\/uploads\\\/2016\\\/12\\\/Graphicloads-Filetype-Pdf-150x150.png\",\"datePublished\":\"2020-02-28T09:10:24+00:00\",\"dateModified\":\"2022-01-04T16:26:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/#\\\/schema\\\/person\\\/8a5e19b3ab1d1aa2190043f3ddb89aa2\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.aica3.org\\\/cms\\\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/wp-content\\\/uploads\\\/2016\\\/12\\\/Graphicloads-Filetype-Pdf.png\",\"contentUrl\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/wp-content\\\/uploads\\\/2016\\\/12\\\/Graphicloads-Filetype-Pdf.png\",\"width\":256,\"height\":256},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Il decorso clinico della calpainopatia (LGMD2A) e della disferlinopatia (LGMD2B)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/#website\",\"url\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/\",\"name\":\"AICa3 - ETS - Associazione Italiana Calpaina 3\",\"description\":\"Sito ufficiale dell\u2019Associazione Italiana Calpaina 3 per la lotta alla Distrofia Muscolare dei cingoli da deficit di Calpaina 3.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/#\\\/schema\\\/person\\\/8a5e19b3ab1d1aa2190043f3ddb89aa2\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b904785971eb1f4a705b7613434a976e92728da57cacd525748a7d680e4cccc?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b904785971eb1f4a705b7613434a976e92728da57cacd525748a7d680e4cccc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b904785971eb1f4a705b7613434a976e92728da57cacd525748a7d680e4cccc?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Il decorso clinico della calpainopatia (LGMD2A) e della disferlinopatia (LGMD2B) - AICa3 - ETS - Associazione Italiana Calpaina 3","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.aica3.org\/cms\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\/","og_locale":"it_IT","og_type":"article","og_title":"Il decorso clinico della calpainopatia (LGMD2A) e della disferlinopatia (LGMD2B) - AICa3 - ETS - Associazione Italiana Calpaina 3","og_description":"The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B) Neurological Research 2010 VOL 32 NO 1 Author: C. Angelini, L. Nardetto, C. Borsato, R. Padoan, M. Fanin, A. C. Nascimbeni and E. Tasca Objective: Autosomal recessive limb girdle muscular dystrophies (LGMD type 2) are a clinically and genetically heterogeneous group of disorders, characterized by progressive […]","og_url":"https:\/\/www.aica3.org\/cms\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\/","og_site_name":"AICa3 - ETS - Associazione Italiana Calpaina 3","article_publisher":"http:\/\/www.facebook.com\/pages\/AICa3-Associazione-Italiana-Calpaina-3\/119599211561350","article_published_time":"2020-02-28T09:10:24+00:00","article_modified_time":"2022-01-04T16:26:49+00:00","og_image":[{"url":"https:\/\/www.aica3.org\/cms\/wp-content\/uploads\/2016\/12\/Graphicloads-Filetype-Pdf-150x150.png","type":"","width":"","height":""}],"author":"admin","twitter_misc":{"Scritto da":"admin","Tempo di lettura stimato":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.aica3.org\/cms\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\/#article","isPartOf":{"@id":"https:\/\/www.aica3.org\/cms\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\/"},"author":{"name":"admin","@id":"https:\/\/www.aica3.org\/cms\/#\/schema\/person\/8a5e19b3ab1d1aa2190043f3ddb89aa2"},"headline":"Il decorso clinico della calpainopatia (LGMD2A) e della disferlinopatia (LGMD2B)","datePublished":"2020-02-28T09:10:24+00:00","dateModified":"2022-01-04T16:26:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.aica3.org\/cms\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\/"},"wordCount":302,"image":{"@id":"https:\/\/www.aica3.org\/cms\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\/#primaryimage"},"thumbnailUrl":"https:\/\/www.aica3.org\/cms\/wp-content\/uploads\/2016\/12\/Graphicloads-Filetype-Pdf-150x150.png","keywords":["Calpain-3","clinical course","dysferlin","LGMD"],"articleSection":["Articoli scientifici","Ricerca e Pubblicazioni"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/www.aica3.org\/cms\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\/","url":"https:\/\/www.aica3.org\/cms\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\/","name":"Il decorso clinico della calpainopatia (LGMD2A) e della disferlinopatia (LGMD2B) - AICa3 - ETS - Associazione Italiana Calpaina 3","isPartOf":{"@id":"https:\/\/www.aica3.org\/cms\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.aica3.org\/cms\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\/#primaryimage"},"image":{"@id":"https:\/\/www.aica3.org\/cms\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\/#primaryimage"},"thumbnailUrl":"https:\/\/www.aica3.org\/cms\/wp-content\/uploads\/2016\/12\/Graphicloads-Filetype-Pdf-150x150.png","datePublished":"2020-02-28T09:10:24+00:00","dateModified":"2022-01-04T16:26:49+00:00","author":{"@id":"https:\/\/www.aica3.org\/cms\/#\/schema\/person\/8a5e19b3ab1d1aa2190043f3ddb89aa2"},"breadcrumb":{"@id":"https:\/\/www.aica3.org\/cms\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.aica3.org\/cms\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.aica3.org\/cms\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\/#primaryimage","url":"https:\/\/www.aica3.org\/cms\/wp-content\/uploads\/2016\/12\/Graphicloads-Filetype-Pdf.png","contentUrl":"https:\/\/www.aica3.org\/cms\/wp-content\/uploads\/2016\/12\/Graphicloads-Filetype-Pdf.png","width":256,"height":256},{"@type":"BreadcrumbList","@id":"https:\/\/www.aica3.org\/cms\/il-decorso-clinico-della-calpainopatia-lgmd2a-e-della-disferlinopatia-lgmd2b\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.aica3.org\/cms\/"},{"@type":"ListItem","position":2,"name":"Il decorso clinico della calpainopatia (LGMD2A) e della disferlinopatia (LGMD2B)"}]},{"@type":"WebSite","@id":"https:\/\/www.aica3.org\/cms\/#website","url":"https:\/\/www.aica3.org\/cms\/","name":"AICa3 - ETS - Associazione Italiana Calpaina 3","description":"Sito ufficiale dell\u2019Associazione Italiana Calpaina 3 per la lotta alla Distrofia Muscolare dei cingoli da deficit di Calpaina 3.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.aica3.org\/cms\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Person","@id":"https:\/\/www.aica3.org\/cms\/#\/schema\/person\/8a5e19b3ab1d1aa2190043f3ddb89aa2","name":"admin","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/4b904785971eb1f4a705b7613434a976e92728da57cacd525748a7d680e4cccc?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4b904785971eb1f4a705b7613434a976e92728da57cacd525748a7d680e4cccc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4b904785971eb1f4a705b7613434a976e92728da57cacd525748a7d680e4cccc?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/www.aica3.org\/cms\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.aica3.org\/cms\/wp-json\/wp\/v2\/posts\/2409","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aica3.org\/cms\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aica3.org\/cms\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aica3.org\/cms\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aica3.org\/cms\/wp-json\/wp\/v2\/comments?post=2409"}],"version-history":[{"count":0,"href":"https:\/\/www.aica3.org\/cms\/wp-json\/wp\/v2\/posts\/2409\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.aica3.org\/cms\/wp-json\/wp\/v2\/media?parent=2409"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aica3.org\/cms\/wp-json\/wp\/v2\/categories?post=2409"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aica3.org\/cms\/wp-json\/wp\/v2\/tags?post=2409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}